Aptyx today announced the acquisition of the Charlotte, North Carolina facility of Medical Murray, which develops and produces catheter-based interventional products and transcatheter implants.
This acquisition will become an integral part of Aptyx Interventional Systems, fortifying the company’s interventional and implantable expertise with a pool of engineering talent.
The transaction enables design and development center support and advanced manufacturing for customers and bolsters expertise in catheter-based interventional products and transcatheter solutions, including implantable stents and frames, complex catheters, and delivery systems. It expands the company’s ISO Class 7 footprint and brings particular expertise in biotextiles such as ePTFE covering for stents and frames. Aptyx has long been known for producing highly engineered products and extreme proficiency in the manufacture of molding, extrusion, coating solutions and medical device assembly. By combining with Medical Murray, Aptyx will now be able to provide a complete manufacturing solution for catheter-based interventional and implantable products.
Charlotte team members will become part of Aptyx. Medical Murray will continue to operate separately through its two facilities in the Chicagoland area.
